A substantial advancement in diabetes management is emerging with the introduction of tirzepatide at a dosage of 45mg. This new offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://dailybookmarkhit.com/story21398912/groundbreaking-introduction-tirzepatide-dose-for-glucose-control